Linical Co

Linical Co EBIT Margin

The EBIT Margin (Operating Margin) of Linical Co (2183.T) as of Nov 7, 2026 is -23.92 %. In the previous year, EBIT Margin (Operating Margin) was -5.59 % — a change of 327.90% (lower).

EBIT Margin

-23.92 %

YoY

327.90%

Last updated:

EBIT Margin (Operating Margin) of Linical Co is 2026 -23.92 % . EBIT Margin (Operating Margin) of Linical Co was 2025 -5.59 % . It decreases by 327.90% lower compared to the previous year.

For Linical Co, the operating (EBIT) margin of -23.9% is down versus 9.4% a few years ago.

The Linical Co EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2019
10.72 JPY
Jan 1, 2020
9.19 JPY
Jan 1, 2021
4.41 JPY
Jan 1, 2022
9.40 JPY
Jan 1, 2023
10.04 JPY
Jan 1, 2024
5.90 JPY
Jan 1, 2025
-5.59 JPY
Jan 1, 2026
-23.92 JPY
The Linical Co EBIT Margin history
YEAREBIT MarginYoY
-23.92 %+327.90%
-5.59 %-194.81%
5.90 %-41.27%
10.04 %+6.84%
9.40 %+113.04%
4.41 %-52.01%
9.19 %-14.26%
10.72 %-47.09%
20.26 %-20.46%
25.48 %-2.95%
26.25 %+45.87%
17.99 %-5.16%
18.97 %+6,706.99%
0.28 %+18.97%
0.23 %+103.76%
0.11 %-42.49%
0.20 %-25.85%
0.27 %-32.03%
0.40 %+30.74%
0.30 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Linical Co Stock analysis

What does Linical Co do? Linical Co., Ltd. generates revenue through two distinct business segments, the CRO segment and the Pharmaceutical Sales Support segment. The CRO segment provides contract monitoring, quality management, and consulting services specifically for phase II and phase III in drug development processes. These services are delivered to pharmaceutical companies as part of pharmaceutical contract research projects. The Pharmaceutical Sales Support segment focuses on the downstream market by providing pharmaceutical sales support for medical institutions. The company operates these businesses from its headquarters in Osaka, Osaka-Fu, leveraging its workforce of 759 full-time employees to deliver these specialized services. Linical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Linical Co stock

EBIT Margin (Operating Margin) of Linical Co is -23.92 % in 2026.

EBIT Margin (Operating Margin) of Linical Co changed from -5.59 % to -23.92 %, representing a 327.90% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Linical Co since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Linical Co with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Linical Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Linical Co